BioLargo Subsidiary Clyra Medical Technologies Adds Two Medical Industry Veterans to its Board of Directors

WESTMINSTER, CA / ACCESSWIRE / February 20, 2023 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech systems and entire-provider environmental engineering business, announced that its subsidiary Clyra Health care Systems, Inc. has added two health-related field veterans as new associates of its board of directors: Nicholas Valeriani and Linda Park.

Nicholas Valeriani has many years of government practical experience in the health care product marketplace. He used 34 several years at Johnson & Johnson, wherever he led several corporate capabilities and was a member of its govt committee. Key positions provided corporate vice president of human methods, globally chairman of health-related gadgets & diagnostics, and Vice President in the Place of work of Method and Expansion. He at the moment serves on the board of directors for Edwards Lifesciences, Surgalign, Inc., SPR Therapeutics, and AgNovos Bioscience. Mr. Valeriani also serves on the board of the Gary and Mary West Health Institute, an unbiased non-financial gain healthcare research corporation whose mission is to help seniors to correctly age in position with obtain to significant high quality, very affordable health care and support products and services. Mr. Valeriani holds a bachelor’s diploma in Industrial Engineering and an MBA from Rutgers University.

Linda Park is a trusted executive and lawful professional with a established track document of supporting and advising public companies. With company board and executive working experience at billion-dollar corporations this sort of as her recent roles performing with Edwards Lifesciences in her capability as Corporate Secretary, Senior Vice President and Associate Basic Counsel, and Board Member of the Edwards Lifesciences Basis, and prior operate with Western Digital Corporation, Linda provides about 20 yrs of experience advancing organizations’ company governance and strategic plans. She also has several years of experience advising issuer and investment decision banking customers on corporate and securities matters, mergers and acquisitions, financial institution financings and money marketplaces, which includes preliminary general public choices. She is also an active partner and assumed chief on environmental, social, and company governance challenges. Linda has an undergraduate degree from Johns Hopkins University, and a law degree from Duke University Faculty of Law.

“We are so happy that Nicholas and Linda have joined Clyra’s board of directors,” stated Steve Harrison, President of Clyra Health care Systems. “Nicholas and Linda the two have intensive practical experience in the health-related market effectively executing on assignments to just take health care merchandise to current market – a monumental endeavor we are at present engaged in. We believe that their abilities will be priceless as Clyra performs to execute agreements in licensing, distributing, and promoting its progressive professional medical solutions, which includes its first – BioClynse, a patented, Fda 510(k)-cleared wound irrigation product or service that is gentle but productive while not making antimicrobial resistance.”

Dennis P. Calvert, President and CEO of BioLargo, commented on the information, “We are so delighted that Clyra now has a clear route ahead of them to commercialize the remarkable merchandise they developed dependent off of BioLargo’s patented technologies. We know that with experts like Nicholas Valeriani and Linda Park delivering vital steering, Clyra’s future is extremely vibrant.”

About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and lifestyle sciences innovator and engineering companies option company. Our main items tackle PFAS contamination, accomplish sophisticated water and wastewater therapy, command odor and VOCs, boost air high-quality, and regulate infections and infectious sickness. Our tactic is to invent or obtain novel technologies, create them into product or service choices, and lengthen their professional access by means of licensing and channel partnerships to increase their affect. See our website at

Speak to Details
Dennis P. Calvert
President and CEO, BioLargo, Inc.

Secure Harbor Act
This push release contains ahead-looking statements in just the this means of the Private Securities Litigation Reform Act of 1995. These forward-searching statements contain devoid of limitation those people about BioLargo’s (the “Firm”) expectations with regards to anticipated profits and designs for future operations, and may well be recognized by words these kinds of as “we imagine”. These statements contain dangers and uncertainties, and genuine success may perhaps differ materially from any foreseeable future success expressed or implied by the ahead-hunting statements. Pitfalls and uncertainties consist of with out limitation: the influence of the COVID-19 pandemic on the Firm’s organization, success of functions, economic affliction, and stock rate the result of worldwide and regional economic circumstances on the Firm’s enterprise, including effects on buying decisions by customers and companies the capacity of the Company to contend in marketplaces that are highly competitive and subject matter to rapid technological alter the ability of the Organization to control recurrent introductions and transitions of products and solutions and companies, like offering to the marketplace, and stimulating client demand for, new solutions, solutions, and technological improvements on a well timed basis the dependency of the Business on the functionality of distributors of the Firm’s goods. Much more information and facts on these hazards and other prospective elements that could have an impact on the Company’s company and money outcomes is integrated in the Company’s filings with the SEC, together with in the “Possibility Aspects” and “Management’s Dialogue and Analysis of Financial Problem and Outcomes of Functions” sections of the Company’s most not long ago submitted periodic experiences on Type 10-K and Type 10-Q and subsequent filings. The Corporation assumes no obligation to update any forward-wanting statements or details, which converse as of their respective dates.

Supply: BioLargo, Inc.

Perspective supply model on

Rachel Pence

Next Post

Clinical Research Trials At Your Local Pharmacy

Mon Feb 20 , 2023
Buoyed by the fast growth of COVID-19 vaccines, the daily life sciences business is on observe for a succession of upheavals by now reworking affected person care, enterprise models, and sector dynamics. In point, it is impossible to individual the transformational threads in between individualized drugs, groundbreaking therapeutic innovations, and […]
Clinical Research Trials At Your Local Pharmacy

You May Like